
Profitability, historical returns, and peer comparisons.
According to NOMAD Power Solutions, Inc.’s latest financial reports and current stock price. The company's current ROE is -74.82%. This represents a change of 196.26% compared to the average of -25.26% of the last 4 quarters.
The mean historical ROE of NOMAD Power Solutions, Inc. over the last ten years is -227.85%. The current -74.82% ROE has changed -67.16% with respect to the historical average. Over the past ten years (40 quarters), NMAD's ROE was at its highest in in the September 2018 quarter at 7.33%. The ROE was at its lowest in in the December 2016 quarter at -240.39%.
Average
-227.85%
Median
-124.78%
Minimum
-994.01%
Maximum
-51.70%
Discovering the peaks and valleys of NOMAD Power Solutions, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 240.42%
Maximum Annual ROE = -51.70%
Minimum Annual Increase = -85.66%
Minimum Annual ROE = -994.01%
| Year | ROE | Change |
|---|---|---|
| 2025 | -62.18% | -85.66% |
| 2024 | -433.50% | 240.42% |
| 2023 | -127.34% | 4.20% |
| 2022 | -122.21% | -12.99% |
| 2021 | -140.46% | 115.62% |
| 2020 | -65.14% | -35.02% |
| 2019 | -100.26% | 93.91% |
| 2018 | -51.70% | -71.55% |
| 2017 | -181.74% | -81.72% |
| 2016 | -994.01% | 8.86% |
The current ROE of NOMAD Power Solutions, Inc. (NMAD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-207.67%
5-year avg
-177.14%
10-year avg
-227.85%
NOMAD Power Solutions, Inc.’s ROE is greater than Kairos Pharma, Ltd. (-98.77%), greater than Lexaria Bioscience Corp. (-160.72%), greater than Allarity Therapeutics, Inc. (-152.77%), greater than Cingulate Inc. (-238.41%), greater than BriaCell Therapeutics Corp. (-170.70%), greater than Pulmatrix, Inc. (-109.26%), greater than Entero Therapeutics, Inc. (-55.12%), greater than Hoth Therapeutics, Inc. (-199.23%), less than Clearside Biomedical, Inc. (20.39%), less than CASI Pharmaceuticals, Inc. (96.40%),
| Company | ROE | Market cap |
|---|---|---|
| -98.77% | $1.79M | |
| -160.72% | $5.77M | |
| -152.77% | $13.85M | |
| -238.41% | $72.42M | |
| -170.70% | $26.55M | |
| -109.26% | $5.11M | |
| -55.12% | $13.58M | |
| -199.23% | $10.62M | |
| 20.39% | $2.15M | |
| 96.40% | $3.09M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NOMAD Power Solutions, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NOMAD Power Solutions, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NOMAD Power Solutions, Inc.'s ROE?
How is the ROE calculated for NOMAD Power Solutions, Inc. (NMAD)?
What is the highest ROE for NOMAD Power Solutions, Inc. (NMAD)?
What is the 3-year average ROE for NOMAD Power Solutions, Inc. (NMAD)?
What is the 5-year average ROE for NOMAD Power Solutions, Inc. (NMAD)?
How does the current ROE for NOMAD Power Solutions, Inc. (NMAD) compare to its historical average?